Nymi partners with POMS to target pharmaceutical manufacturing for biometric e-signing
Toronto-based biometric authentication company Nymi has signed a strategic partnership with POMS Corporation to consolidate its position in the pharmaceutical manufacturing market by delivering secure compliance, data integrity and enhanced productivity, the company announced.
Under the partnership, POMS has integrated the Nymi solution for authenticated e-signing that users can now benefit from in the POMSnet Manufacturing Execution System. POMSnet users can perform continuous authentication and e-signature authorizations with their Nymi bands, while POMS Corporation customers can use Nymi to improve efficiency in their environment.
“We see a huge efficiency gain for our customers,” says Darrell Tanner, director, sales and consulting services at POMS. “We’ve found that on average, an electronic e-signature can take 10-15 seconds when it’s done correctly and much longer if it’s not done correctly. If you look at this from the perspective of hundreds of e-signatures a day, Nymi is going to be able to help our customers cut this time down and be more secure and productive at the same time.”
Nymi boasts a customer portfolio of top 100 pharmaceutical manufacturers, and says five of the world’s 10 largest and 13 of the top 50 pharmaceutical companies in the Global Fortune 500 use the POMSnet Manufacturing Execution System.
“POMS has been a proactive and focused partner,” said Andrew Foxcroft, vice president at Nymi. “Their customers can expect to experience significant benefits out of this partnership. This includes delivery and rapid implementation to the integration of its core platform.”
“We want to get this technology out in front of our customers so they can start to recognize the benefits of this technology,” said POMS General Manager Patrick Nazzaro. “It’s not just about an e-signature; the validation process goes beyond that. The ability to scale this service will continue to bring efficiency and greater reliability and certainty to the process.”
Nymi is a venture-funded private company whose investors include Relay Ventures, GII Tech Ventures, Mastercard, Konica Minolta, and Export Development Canada.
In October, Nymi appointed cybersecurity industry veteran Chris Sullivan as its new Chief Executive Officer. This summer, Nymi signed a partnership with Systec & Solutions to develop a joint solution for secure e-signature and login authentication, pitching biometrics as answer to healthcare industry cybersecurity threats. The biometric company also announced a partnership with Rockwell Automation’s ThinManager to ensure safety and security in factories through continuous user authentication for their customers.